Support independent, student-run journalism.

Your support helps give staff members from all backgrounds the opportunity to conduct meaningful reporting on important issues at Stanford. All contributions are tax-deductible.

Stanford researchers criticize Theranos-like biomedical ‘unicorns’ for lack of published research

Today, a new generation of innovative biomedical startups continue to win billion-dollar valuations and massive infusions of venture capital as they promise to revolutionize medicine and disrupt massive healthcare markets. According to a new January paper authored by three Stanford researchers, many of these companies also publish little to no peer-reviewed research.

Stanford researchers develop new, ‘three-dimensional’ CRISPR technology

On Thursday, a team led by assistant professor of bioengineering Stanley Qi released a study on a new form of gene-editing technology known as Clustered Regularly Interspaced Short Palindromic Repeats genome organization, or CRISPR-GO, which allows scientists to move pieces of DNA within a cell nucleus. In contrast, previous CRISPR technology has been used to “cut” and “paste” sections of the genetic code within individual pieces of DNA.